Literature DB >> 26882840

Regulators in the DNA damage response.

Yunhua Liu1, Yujing Li2, Xiongbin Lu3.   

Abstract

Maintenance of genome integrity is essential for the proper function of all cells and organisms. In response to both endogenous and exogenous DNA damaging agents, mammalian cells have evolved a delicate system to sense DNA damage, stop cell cycle progression, modulate cell metabolism, repair damaged DNA, and induce programmed cell death if the damage is too severe. This coordinated global signaling network, namely the DNA damage response (DDR), ensures the genome stability under DNA damaging stress. A variety of regulators have been shown to modulate the activity and levels of key proteins in the DDR, including kinases, phosphatases, ubiquitin ligases, deubiquitinases, and other protein modifying enzymes. Epigenetic regulators, particularly microRNAs and long noncoding RNAs, have been emerging as an important payer of regulation in addition to canonical DNA damage signaling proteins. In this review, we will discuss the functional interaction between the regulators and their targets in the DDR.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA damage response; Long noncoding RNA; Noncoding RNA; Posttranslational modification; microRNA

Mesh:

Substances:

Year:  2016        PMID: 26882840     DOI: 10.1016/j.abb.2016.02.018

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  16 in total

1.  DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21WAF1/CIP1.

Authors:  Shun Xu; Haijiao Huang; Yu-Ning Chen; Yun-Ting Deng; Bing Zhang; Xing-Dong Xiong; Yuan Yuan; Yanmei Zhu; Haiyong Huang; Luoyijun Xie; Xinguang Liu
Journal:  Cell Cycle       Date:  2016-08-25       Impact factor: 4.534

Review 2.  Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer.

Authors:  Marilyne Labrie; Joan S Brugge; Gordon B Mills; Ioannis K Zervantonakis
Journal:  Nat Rev Cancer       Date:  2022-03-09       Impact factor: 69.800

Review 3.  Heat-shock proteins: chaperoning DNA repair.

Authors:  Laurence Dubrez; Sébastien Causse; Natalia Borges Bonan; Baptiste Dumétier; Carmen Garrido
Journal:  Oncogene       Date:  2019-09-20       Impact factor: 9.867

Review 4.  The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin.

Authors:  Monika D Scuron; Kathleen Boesze-Battaglia; Mensur Dlakić; Bruce J Shenker
Journal:  Front Cell Infect Microbiol       Date:  2016-12-05       Impact factor: 5.293

Review 5.  Aberrant DNA Double-strand Break Repair Threads in Breast Carcinoma: Orchestrating Genomic Insult Survival.

Authors:  Azad Kumar; Shruti Purohit; Nilesh Kumar Sharma
Journal:  J Cancer Prev       Date:  2016-12-30

6.  Deficiency in DNA damage response of enterocytes accelerates intestinal stem cell aging in Drosophila.

Authors:  Joung-Sun Park; Ho-Jun Jeon; Jung-Hoon Pyo; Young-Shin Kim; Mi-Ae Yoo
Journal:  Aging (Albany NY)       Date:  2018-03-07       Impact factor: 5.682

7.  P53 and taurine upregulated gene 1 promotes the repair of the DeoxyriboNucleic Acid damage induced by bupivacaine in murine primary sensory neurons.

Authors:  Luying Lai; Yongwei Wang; Shenghui Peng; Wenjing Guo; Fengxian Li; Shiyuan Xu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

Review 8.  DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets.

Authors:  Adan Pinto-Fernandez; Benedikt M Kessler
Journal:  Front Genet       Date:  2016-07-28       Impact factor: 4.599

Review 9.  Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer.

Authors:  Enea Gino Di Domenico; Ilaria Cavallo; Martina Pontone; Luigi Toma; Fabrizio Ensoli
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

Review 10.  Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.

Authors:  Pierpaola Davalli; Gaetano Marverti; Angela Lauriola; Domenico D'Arca
Journal:  Oxid Med Cell Longev       Date:  2018-03-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.